文献速递青光眼

原发性闭角型青光眼手术格局中的微创青光眼手术:现状创新与未来趋势

Minimally invasive glaucoma surgery in the surgical landscape of primary angle closure glaucoma: Current innovations and future trends.
PubMed 文献 · Prog Retin Eye Res · 2026-04-24

原发性闭角型青光眼(PACG)是全球不可逆盲的主要原因,亚洲负担最重。传统手术(小梁切除术、晶状体摘除、经巩膜睫状体光凝)降压效果明显但风险高、恢复慢。微创青光眼手术(MIGS)在房角入口恢复后提供更安全、更早、靶向机制的干预选择,联合晶状体摘除可加深前房、解除周边虹膜前粘连、恢复生理性房水外流,临床证据显示眼压降低20-50%并减少用药负担。本文综述MIGS用于PACG的解剖、生理和临床证据,讨论其补充或替代传统滤过手术的潜力及未来方向。

要点

  • MIGS为PACG提供更安全、更早、机制靶向的干预选择,需先恢复房角入口。
  • 联合晶状体摘除可加深前房、解除周边虹膜前粘连、恢复生理性房水外流。
  • 临床证据显示MIGS联合晶状体摘除可使眼压降低20-50%并减少用药负担。

核心结论

  • MIGS可补充或在选定病例中替代传统滤过手术,实现更早干预并保持良好安全性。
  • 未来进展取决于窄角眼器械改良、影像引导精准化、生物调节及成本效益与可及性策略。

研究设计与样本

  • 综述文章,总结MIGS用于PACG的解剖、生理和临床证据。

主要发现

  • PACG发病机制涉及瞳孔阻滞、高褶虹膜构型、晶状体相关拥挤和动态脉络膜扩张等多机制相互作用。
  • MIGS技术涵盖小梁网和Schlemm管途径、结膜下支架及睫状体途径。
  • MIGS联合晶状体摘除可加深前房、解除周边虹膜前粘连并恢复生理性房水外流。
  • 临床证据显示MIGS联合晶状体摘除可使眼压降低20-50%并减少用药负担。

关键数值与推荐

  • MIGS联合晶状体摘除的临床证据显示眼压降低20-50%并减少用药负担。

临床怎么用

  • 在房角入口恢复后,可考虑MIGS作为PACG更安全、更早、机制靶向的干预选择。
  • MIGS可补充传统滤过手术,在选定病例中可能替代传统滤过手术。

局限性

  • 本文为综述,未报告原始研究的具体样本量、置信区间或P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary angle-closure glaucoma (PACG) is a major cause of irreversible blindness worldwide, with the highest burden in Asia. Its pathogenesis involves the interplay of multiple mechanisms, including pupillary block, plateau iris configuration, lens-related crowding, and dynamic choroidal expansion. Traditional surgical management has relied on trabeculectomy, lens extraction, or transscleral cyclophotocoagulation, which often achieve substantial intraocular pressure (IOP) control but carry significant risks and require prolonged recovery. Minimally invasive glaucoma surgery (MIGS) expands treatment options for PACG once angle access is restored. It offers safer, earlier, and targeted interventions tailored to the underlying mechanisms. Techniques range from trabecular meshwork (TM) and Schlemm's canal-based procedures to subconjunctival stents and ciliary body approaches. Combined with lens extraction, these methods deepen the anterior chamber, release peripheral anterior synechiae, and restore physiological outflow, with clinical evidence showing 20-50% IOP reductions and reduced medication burden. This paper reviews anatomical, physiological, and clinical evidence for the use of MIGS in PACG, discussing how these procedures can complement, or in selected cases replace, invasive filtration surgery, potentially enabling earlier intervention while maintaining a favorable safety profile. Future advancements will hinge on device refinements for narrow-angle eyes, imaging-guided precision, biologic modulation, and strategies to enhance cost-effectiveness and accessibility, ultimately enabling individualized, mechanism-based treatment pathways.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Li F, Lin F, Yang Z, et al. Minimally invasive glaucoma surgery in the surgical landscape of primary angle closure glaucoma: Current innovations and future trends. Prog Retin Eye Res. 2026. PMID: 42035831. doi:10.1016/j.preteyeres.2026.101470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。